Pharma’s Digital Disruptor: How virtual trials are transforming the clinical research experience

Sponsored by: IQVIA
Speakers:

Jessica Perry, Director of Virtual Site Operations at IQVIA – session chair
Dr. Lindsay McNair, MD, MPH, MSB, Chief Medical Officer, WIRB-Copernicus Group (WCG)
Abby Doctolero, Clinical Operations, Pear Therapeutics

Tuesday - November 5, 2019 / 1:00pm ET
Free Event

Virtual Trial models bring clinical research directly to patients to reduce burdens and improve engagement. These innovative models offer operational flexibility to better meet the unique needs of a trial and its key stakeholders.

In this webinar, we will discuss:

* How early adopter studies are applying virtual trial models in different ways to achieve more rapid patient enrollment, higher retention, better data quality and overall faster cycle times.

* Lessons learned from different types of virtual trials – from 100% virtual to hybrid models blending remote and site-based visits.

* How the regulatory environment is evolving to respond to virtual trials, and how early planning can support a sponsor’s long-term success.

 

About the Sponsors

IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare - and human health - forward. Together with the companies we serve, we are enabling a more modern, more effective and more efficient healthcare system, and creating breakthrough solutions that transform business and patient outcomes.

For more information please visit www.iqvia.com/.

Comments are closed.

FEEDBACK